Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

BAJAJ HEALTHCARE 2023-24 Annual Report Analysis
Tue, 24 Sep

BAJAJ HEALTHCARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

BAJAJ HEALTHCARE Income Statement Analysis

  • Operating income during the year fell 26.7% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 71.3% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 6.8% in FY24 as against 17.3% in FY23.
  • Depreciation charges increased by 60.5% and finance costs increased by 68.3% YoY, respectively.
  • Other income grew by 446.3% YoY.
  • Net profit for the year declined by NA YoY.
  • Net profit margins during the year declined from 9.8% in FY23 to 3.0% in FY24.

BAJAJ HEALTHCARE Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 6,458 4,734 -26.7%
Other income Rs m 16 87 446.3%
Total Revenues Rs m 6,474 4,821 -25.5%
Gross profit Rs m 1,115 320 -71.3%
Depreciation Rs m 172 276 60.5%
Interest Rs m 177 297 68.3%
Profit before tax Rs m 782 -167 NA
Tax Rs m 147 -23 NA
Profit after tax Rs m 635 -143 NA
Gross profit margin % 17.3 6.8
Effective tax rate % 18.7 14.1
Net profit margin % 9.8 -3.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Dear Reader: If You Invest in Midcap Stocks, this is for You

BAJAJ HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY24 down at Rs 4 billion as compared to Rs 4 billion in FY23, thereby witnessing an decrease of -7.6%.
  • Long-term debt down at Rs 386 million as compared to Rs 937 million during FY23, a fall of 58.8%.
  • Current assets fell 19% and stood at Rs 4 billion, while fixed assets fell 34% and stood at Rs 3 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 7 billion as against Rs 9 billion during FY23, thereby witnessing a fall of 17%.

BAJAJ HEALTHCARE Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 3,677 2,784 -24.3
 
Current Liabilities Rs m 4,352 4,021 -7.6
Long-term Debt Rs m 937 386 -58.8
Total Liabilities Rs m 8,993 7,433 -17.3
 
Current assets Rs m 5,020 4,045 -19.4
Fixed Assets Rs m 3,973 2,632 -33.7
Total Assets Rs m 8,993 7,433 -17.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



BAJAJ HEALTHCARE Cash Flow Statement Analysis

  • BAJAJ HEALTHCARE's cash flow from operating activities (CFO) during FY24 stood at Rs 923 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -112 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -966 million on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -155 million from the Rs 157 million net cash flows seen during FY23.

BAJAJ HEALTHCARE Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m -222 923 -
Cash Flow from Investing Activities Rs m -934 -112 -
Cash Flow from Financing Activities Rs m 1,314 -966 -
Net Cash Flow Rs m 157 -155 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for BAJAJ HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs -5.2, an decline from the EPS of Rs 23.0 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 388.8, stands at -80.5 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.9 times, while the price to sales ratio stands at 2.3 times.
  • The company's price to cash flow (P/CF) ratio stood at 78.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 234.0 171.5
TTM Earnings per share Rs 23.0 -5.2
Diluted earnings per share Rs 23.0 -5.2
Price to Cash Flow x 10.4 78.5
TTM P/E ratio x 13.2 -80.5
Price / Book Value ratio x 2.7 3.7
Market Cap Rs m 9,857 10,433
Dividends per share (Unadj.) Rs 1.0 1.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for BAJAJ HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.0x during FY24, from 1.2x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 0.4x during FY24, from 5.4x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at -5.1% during FY24, from 17.3% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 4.1% during FY24, from 20.8% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 2.1% during FY24, from 9.0% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 1.2 1.0
Debtors’ Days Days 1,097 1,390
Interest coverage x 5.4 0.4
Debt to equity ratio x 0.3 0.1
Return on assets % 9.0 2.1
Return on equity % 17.3 -5.1
Return on capital employed % 20.8 4.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how BAJAJ HEALTHCARE has performed over the last 5 years, please visit here.

BAJAJ HEALTHCARE Share Price Performance

Over the last one year, BAJAJ HEALTHCARE share price has moved down from Rs 464.9 to Rs 388.8, registering a loss of Rs 76.1 or around 16.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 44,351.3 (up 0.3%). Over the last one year it has moved up from 27,763.9 to 44,351.3, a gain of 16,587 points (up 59.7%).

Overall, the S&P BSE SENSEX is up 27.3% over the year.

(To know more, check out historical annual results for BAJAJ HEALTHCARE and quarterly results for BAJAJ HEALTHCARE)

Annual Report FAQs

What is the current share price of BAJAJ HEALTHCARE?

BAJAJ HEALTHCARE currently trades at Rs 390.7 per share. You can check out the latest share price performance of BAJAJ HEALTHCARE here...

What was the revenue of BAJAJ HEALTHCARE in FY24? How does it compare to earlier years?

The revenues of BAJAJ HEALTHCARE stood at Rs 4,821 m in FY24, which was down -25.5% compared to Rs 6,474 m reported in FY23.

BAJAJ HEALTHCARE's revenue has grown from Rs 4,165 m in FY20 to Rs 4,821 m in FY24.

Over the past 5 years, the revenue of BAJAJ HEALTHCARE has grown at a CAGR of 3.7%.

What was the net profit of BAJAJ HEALTHCARE in FY24? How does it compare to earlier years?

The net loss of BAJAJ HEALTHCARE stood at Rs -143 m in FY24, which was NA compared to Rs 635 m reported in FY23.

This compares to a net profit of Rs 714 m in FY22 and a net profit of Rs 831 m in FY21.

Over the past 5 years, BAJAJ HEALTHCARE net profit has grown at a CAGR of NaN%.

What does the cash flow statement of BAJAJ HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of BAJAJ HEALTHCARE reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 923 m as compared to Rs -222 m in FY23.
  • Cash flow from investments increased in FY24 and stood at Rs -112 m as compared to Rs -934 m in FY23.
  • Cash flow from financial activity decreased in FY24 and stood at Rs -966 m as compared to Rs 1,314 m in FY23.

Here's the cash flow statement of BAJAJ HEALTHCARE for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations2064367-222923
From Investments-276-1,089-748-934-112
From Financial Activity337556181,314-966
Net Cashflow-37101-123157-155

What does the Key Ratio analysis of BAJAJ HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of BAJAJ HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and stood at 6.8% in FY24 as against 17.3% in FY23.
  • Net profit margins declined from 9.8% in FY23 to 3.0% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.1 as compared to 0.3 in FY23.

Here's the ratio/financial analysis of BAJAJ HEALTHCARE for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)11.820.817.517.36.8
Net Profit Margin (%)6.212.710.59.8-3.0
Debt to Equity Ratio (x)0.10.30.20.30.1

 

Equitymaster requests your view! Post a comment on "BAJAJ HEALTHCARE 2023-24 Annual Report Analysis". Click here!